Ms. Lisa W. Pompa currently works for Spark Therapeutics, a leader in gene therapy for rare genetic illness, where she directs their payer strategy and all assets and strategy for the Market Access Team. She has 17 years of healthcare reimbursement experience and 33 years of experience in the commercial biotech industry.
Ms. Pompa received her Bachelor of Science in Biology degree from Radford University in 1986 and currently serves on the Radford University Alumni Association Board of Directors.
Ms. Pompa was appointed in 2021 by Governor Ralph Northam.
Ms. Pompa's term expires June 30, 2025.